ID   TEX14_HUMAN             Reviewed;        1497 AA.
AC   Q8IWB6; A6NH19; Q7RTP3; Q8ND97; Q9BXT9;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   16-JAN-2019, entry version 147.
DE   RecName: Full=Inactive serine/threonine-protein kinase TEX14;
DE   AltName: Full=Protein kinase-like protein SgK307;
DE   AltName: Full=Sugen kinase 307;
DE   AltName: Full=Testis-expressed sequence 14;
DE   AltName: Full=Testis-expressed sequence 14 protein;
GN   Name=TEX14; Synonyms=SGK307;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 480-1497 (ISOFORM 3), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11279525; DOI=10.1038/86927;
RA   Wang P.J., McCarrey J.R., Yang F., Page D.C.;
RT   "An abundance of X-linked genes expressed in spermatogonia.";
RL   Nat. Genet. 27:422-426(2001).
RN   [5]
RP   IDENTIFICATION, AND ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=12711554; DOI=10.1016/S1567-133X(03)00036-X;
RA   Wu M.-H., Rajkovic A., Burns K.H., Yan W., Lin Y.-N., Matzuk M.M.;
RT   "Sequence and expression of testis-expressed gene 14 (Tex14): a gene
RT   encoding a protein kinase preferentially expressed during
RT   spermatogenesis.";
RL   Gene Expr. Patterns 3:231-236(2003).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CEP55.
RX   PubMed=20176808; DOI=10.1128/MCB.01392-09;
RA   Iwamori T., Iwamori N., Ma L., Edson M.A., Greenbaum M.P.,
RA   Matzuk M.M.;
RT   "TEX14 interacts with CEP55 to block cell abscission.";
RL   Mol. Cell. Biol. 30:2280-2292(2010).
RN   [7]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF 614-SER--THR-618 AND
RP   726-SER--THR-728.
RX   PubMed=22405274; DOI=10.1016/j.molcel.2012.01.013;
RA   Mondal G., Ohashi A., Yang L., Rowley M., Couch F.J.;
RT   "Tex14, a plk1-regulated protein, is required for kinetochore-
RT   microtubule attachment and regulation of the spindle assembly
RT   checkpoint.";
RL   Mol. Cell 45:680-695(2012).
RN   [8]
RP   INVOLVEMENT IN SPGF23, AND TISSUE SPECIFICITY.
RX   PubMed=28206990; DOI=10.1038/gim.2016.225;
RA   Gershoni M., Hauser R., Yogev L., Lehavi O., Azem F., Yavetz H.,
RA   Pietrokovski S., Kleiman S.E.;
RT   "A familial study of azoospermic men identifies three novel causative
RT   mutations in three new human azoospermia genes.";
RL   Genet. Med. 19:998-1006(2017).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-88; GLU-321; CYS-443 AND MET-559.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required both for the formation of intercellular bridges
CC       during meiosis and for kinetochore-microtubule attachment during
CC       mitosis. Intercellular bridges are evolutionarily conserved
CC       structures that connect differentiating germ cells and are
CC       required for spermatogenesis and male fertility. Acts by promoting
CC       the conversion of midbodies into intercellular bridges via its
CC       interaction with CEP55: interaction with CEP55 inhibits the
CC       interaction between CEP55 and PDCD6IP/ALIX and TSG101, blocking
CC       cell abscission and leading to transform midbodies into
CC       intercellular bridges. Also plays a role during mitosis: recruited
CC       to kinetochores by PLK1 during early mitosis and regulates the
CC       maturation of the outer kinetochores and microtubule attachment.
CC       Has no protein kinase activity in vitro (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with KIF23 and RBM44. Interacts with CEP55;
CC       inhibiting interaction between CEP55 and PDCD6IP/ALIX and TSG101
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q53EZ4:CEP55; NbExp=3; IntAct=EBI-6674697, EBI-747776;
CC       P61968:LMO4; NbExp=4; IntAct=EBI-6674697, EBI-2798728;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Midbody
CC       {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000250}.
CC       Note=Detected in the intercellular bridges that connect male germ
CC       cell daughter cells after cell division. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IWB6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWB6-2; Sequence=VSP_019868;
CC       Name=3;
CC         IsoId=Q8IWB6-3; Sequence=VSP_019868, VSP_019869;
CC   -!- TISSUE SPECIFICITY: Expression restricted to testis.
CC       {ECO:0000269|PubMed:11279525, ECO:0000269|PubMed:28206990}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- DOMAIN: The GPPX3Y motif mediates interaction with CEP55.
CC   -!- PTM: Phosphorylated on Thr residues by CDK1 during early phases of
CC       mitosis, promoting the interaction with PLK1 and recruitment to
CC       kinetochores. Phosphorylated on Ser-437 by PLK1 during late
CC       prometaphase promotes the rapid depletion from kinetochores and
CC       its subsequent degradation by the APC/C complex.
CC       {ECO:0000269|PubMed:22405274}.
CC   -!- DISEASE: Spermatogenic failure 23 (SPGF23) [MIM:617707]: An
CC       infertility disorder caused by spermatogenesis defects that result
CC       in non-obstructive azoospermia. {ECO:0000269|PubMed:28206990}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Ser-376 is present instead of the conserved Asp which is
CC       expected to be an active site residue. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK31980.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL834143; CAD38856.2; -; mRNA.
DR   EMBL; AC005666; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040526; AAH40526.1; -; mRNA.
DR   EMBL; AF285601; AAK31980.1; ALT_INIT; mRNA.
DR   EMBL; BK000998; DAA01359.1; -; mRNA.
DR   CCDS; CCDS32692.1; -. [Q8IWB6-3]
DR   CCDS; CCDS32693.1; -. [Q8IWB6-2]
DR   CCDS; CCDS56042.1; -. [Q8IWB6-1]
DR   RefSeq; NP_001188386.1; NM_001201457.1. [Q8IWB6-1]
DR   RefSeq; NP_112562.3; NM_031272.4. [Q8IWB6-3]
DR   RefSeq; NP_938207.2; NM_198393.3. [Q8IWB6-2]
DR   UniGene; Hs.390221; -.
DR   PDB; 3WUT; X-ray; 2.30 A; C/F/I/L=792-804.
DR   PDB; 3WUU; X-ray; 2.90 A; C/F/I/L=791-805.
DR   PDBsum; 3WUT; -.
DR   PDBsum; 3WUU; -.
DR   ProteinModelPortal; Q8IWB6; -.
DR   SMR; Q8IWB6; -.
DR   BioGrid; 121089; 3.
DR   ELM; Q8IWB6; -.
DR   IntAct; Q8IWB6; 5.
DR   STRING; 9606.ENSP00000240361; -.
DR   TCDB; 1.A.87.2.7; the mechanosensitive calcium channel (mca) family.
DR   iPTMnet; Q8IWB6; -.
DR   PhosphoSitePlus; Q8IWB6; -.
DR   BioMuta; TEX14; -.
DR   DMDM; 110816441; -.
DR   jPOST; Q8IWB6; -.
DR   PaxDb; Q8IWB6; -.
DR   PeptideAtlas; Q8IWB6; -.
DR   PRIDE; Q8IWB6; -.
DR   ProteomicsDB; 70835; -.
DR   ProteomicsDB; 70836; -. [Q8IWB6-2]
DR   ProteomicsDB; 70837; -. [Q8IWB6-3]
DR   DNASU; 56155; -.
DR   Ensembl; ENST00000240361; ENSP00000240361; ENSG00000121101. [Q8IWB6-1]
DR   Ensembl; ENST00000349033; ENSP00000268910; ENSG00000121101. [Q8IWB6-3]
DR   Ensembl; ENST00000389934; ENSP00000374584; ENSG00000121101. [Q8IWB6-2]
DR   GeneID; 56155; -.
DR   KEGG; hsa:56155; -.
DR   UCSC; uc002iwr.3; human. [Q8IWB6-1]
DR   CTD; 56155; -.
DR   DisGeNET; 56155; -.
DR   EuPathDB; HostDB:ENSG00000121101.15; -.
DR   GeneCards; TEX14; -.
DR   HGNC; HGNC:11737; TEX14.
DR   HPA; HPA030620; -.
DR   HPA; HPA077020; -.
DR   MalaCards; TEX14; -.
DR   MIM; 605792; gene.
DR   MIM; 617707; phenotype.
DR   neXtProt; NX_Q8IWB6; -.
DR   OpenTargets; ENSG00000121101; -.
DR   PharmGKB; PA36454; -.
DR   eggNOG; ENOG410IHZA; Eukaryota.
DR   eggNOG; ENOG410XT67; LUCA.
DR   GeneTree; ENSGT00390000015123; -.
DR   HOGENOM; HOG000059264; -.
DR   HOVERGEN; HBG094035; -.
DR   InParanoid; Q8IWB6; -.
DR   KO; K17540; -.
DR   OMA; LEYMMES; -.
DR   OrthoDB; 92703at2759; -.
DR   PhylomeDB; Q8IWB6; -.
DR   TreeFam; TF328704; -.
DR   ChiTaRS; TEX14; human.
DR   GenomeRNAi; 56155; -.
DR   PRO; PR:Q8IWB6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000121101; Expressed in 102 organ(s), highest expression level in testis.
DR   CleanEx; HS_TEX14; -.
DR   ExpressionAtlas; Q8IWB6; baseline and differential.
DR   Genevisible; Q8IWB6; HS.
DR   GO; GO:0005623; C:cell; ISS:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISS:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; ISS:UniProtKB.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0043063; P:intercellular bridge organization; ISS:UniProtKB.
DR   GO; GO:0007140; P:male meiotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0051306; P:mitotic sister chromatid separation; ISS:UniProtKB.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; ISS:UniProtKB.
DR   GO; GO:0032466; P:negative regulation of cytokinesis; IEA:Ensembl.
DR   GO; GO:0032091; P:negative regulation of protein binding; IEA:Ensembl.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR039339; Tex14.
DR   PANTHER; PTHR23060; PTHR23060; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; ATP-binding;
KW   Cell cycle; Cell division; Centromere; Chromosome; Complete proteome;
KW   Cytoplasm; Kinetochore; Mitosis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1   1497       Inactive serine/threonine-protein kinase
FT                                TEX14.
FT                                /FTId=PRO_0000246995.
FT   REPEAT       27     54       ANK 1.
FT   REPEAT       55     84       ANK 2.
FT   REPEAT       88    117       ANK 3.
FT   DOMAIN      227    518       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     233    241       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       795    801       GPPX3Y.
FT   MOTIF       852    860       D-box.
FT   BINDING     273    273       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     175    175       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1M5M3}.
FT   MOD_RES     437    437       Phosphoserine; by PLK1.
FT                                {ECO:0000250|UniProtKB:Q7M6U3}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1M5M3}.
FT   MOD_RES     665    665       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1M5M3}.
FT   MOD_RES    1106   1106       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7M6U3}.
FT   MOD_RES    1404   1404       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7M6U3}.
FT   MOD_RES    1459   1459       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7M6U3}.
FT   MOD_RES    1496   1496       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7M6U3}.
FT   VAR_SEQ     213    218       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11279525,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019868.
FT   VAR_SEQ    1064   1103       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11279525,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019869.
FT   VARIANT      88     88       D -> G (in dbSNP:rs56292204).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041388.
FT   VARIANT     321    321       K -> E (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041389.
FT   VARIANT     443    443       S -> C. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041390.
FT   VARIANT     559    559       I -> M. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041391.
FT   MUTAGEN     614    618       SSPST->AAPAA: In PBD-1; reduced ability
FT                                to interact with PLK1.
FT                                {ECO:0000269|PubMed:22405274}.
FT   MUTAGEN     726    728       STT->AAA: In PBD-5; reduced ability to
FT                                interact with PLK1.
FT                                {ECO:0000269|PubMed:22405274}.
FT   CONFLICT   1326   1326       H -> R (in Ref. 4; AAK31980).
FT                                {ECO:0000305}.
FT   CONFLICT   1387   1387       L -> P (in Ref. 1; CAD38856).
FT                                {ECO:0000305}.
FT   STRAND      797    800       {ECO:0000244|PDB:3WUT}.
SQ   SEQUENCE   1497 AA;  167901 MW;  D7DC446A1A18FC4D CRC64;
     MSRAVRLPVP CPVQLGTLRN DSLEAQLHEY VKQGNYVKVK KILKKGIYVD AVNSLGQTAL
     FVAALLGLRK FVDVLVDYGS DPNHRCFDGS TPVHAAAFSG NQWILSKLLD AGGDLRLHDE
     RGQNPKTWAL TAGKERSTQI VEFMQRCASH MQAIIQGFSY DLLKKIDSPQ RLVYSPSWCG
     GLVQGNPNGS PNRLLKAGVI SAQNIYSFGF GKAMPWFQFY LTGATQMAYL GSLPVIGEKE
     VIQADDEPTF SFFSGPYMVM TNLVWNGSRV TVKELNLPTH PHCSRLRLAD LLIAEQEHSS
     KLRHPYLLQL MAVCLSQDLE KTRLVYERIT IGTLFSVLHE RRSQFPVLHM EVIVHLLLQI
     SDALRYLHFQ GFIHRSLSSY AVHIISPGEA RLTNLEYMLE SEDRGVQRDL TRVPLPTQLY
     NWAAPEVILQ KAATVKSDIY SFSMIMQEIL TDDIPWKGLD GSVVKKAVVS GNYLEADVRL
     PKPYYDIVKS GIHVKQKDRT MNLQDIRYIL KNDLKDFTGA QRTQPTESPR VQRYGLHPDV
     NVYLGLTSEH PRETPDMEII ELKEMGSQPH SPRVHSLFTE GTLDPQAPDP CLMARETQNQ
     DAPCPAPFMA EEASSPSTGQ PSLCSFEINE IYSGCLILED DIEEPPGAAS SLEADGPNQV
     DELKSMEEEL DKMEREACCF GSEDESSSKA ETEYSFDDWD WQNGSLSSLS LPESTREAKS
     NLNNMSTTEE YLISKCVLDL KIMQTIMHEN DDRLRNIEQI LDEVEMKQKE QEERMSLWAT
     SREFTNAYKL PLAVGPPSLN YIPPVLQLSG GQKPDTSGNY PTLPRFPRML PTLCDPGKQN
     TDEQFQCTQG AKDSLETSRI QNTSSQGRPR ESTAQAKATQ FNSALFTLSS HRQGPSASPS
     CHWDSTRMSV EPVSSEIYNA ESRNKDDGKV HLKWKMEVKE MAKKAATGQL TVPPWHPQSS
     LTLESEAENE PDALLQPPIR SPENTDWQRV IEYHRENDEP RGNGKFDKTG NNDCDSDQHG
     RQPRLGSFTS IRHPSPRQKE QPEHSEAFQA SSDTLVAVEK SYSHQSMQST CSPESSEDIT
     DEFLTPDGEY FYSSTAQENL ALETSSPIEE DFEGIQGAFA QPQVSGEEKF QMRKILGKNA
     EILPRSQFQP VRSTEDEQEE TSKESPKELK EKDISLTDIQ DLSSISYEPD SSFKEASCKT
     PKINHAPTSV STPLSPGSVS SAASQYKDCL ESITFQVKTE FASCWNSQEF IQTLSDDFIS
     VRERAKKLDS LLTSSETPPS RLTGLKRLSS FIGAGSPSLV KACDSSPPHA TQRRSLPKVE
     AFSQHHIDEL PPPSQELLDD IELLKQQQGS STVLHENTAS DGGGTANDQR HLEEQETDSK
     KEDSSMLLSK ETEDLGEDTE RAHSTLDEDL ERWLQPPEES VELQDLPKGS ERETNIKDQK
     VGEEKRKRED SITPERRKSE GVLGTSEEDE LKSCFWKRLG WSESSRIIVL DQSDLSD
//